Skip to main content
Apotea AB logo

Apotea AB — Investor Relations & Filings

Ticker · APOTEA ISIN · SE0023313762 LEI · 6367005D3D7BO6FIEV09 ST Wholesale and retail trade
Open in API
Filings indexed 63 across all filing types
Latest filing 2025-05-13 Major Shareholding Noti…
Country SE Sweden
Listing ST APOTEA

About Apotea AB

https://www.apotea.se/

Apotea AB operates as an online-only pharmacy. The company offers a comprehensive range of both prescription and over-the-counter medications for humans and animals. Its extensive catalog also includes thousands of products related to health, beauty, skincare, vitamins, and minerals. Apotea provides pharmaceutical consultation and support via email, phone, and chat. The business model focuses on providing fast deliveries, competitive pricing, and a product assortment that is broader than that of traditional brick-and-mortar pharmacies.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2025
Major Shareholding Notification Classification · 1% confidence The document is a 'flaggningsmeddelande' (flagging notification) filed with the Swedish Financial Supervisory Authority (Finansinspektionen). It details a change in shareholding by Societe Generale SA in Apotea AB, specifically crossing a 5% threshold. This type of disclosure regarding significant changes in ownership is classified as a Major Shareholding Notification.
2025-05-13 Swedish
Major Shareholding Notification 2025
Major Shareholding Notification Classification · 1% confidence The document is a regulatory filing submitted to the Swedish Financial Supervisory Authority (Finansinspektionen) regarding a change in shareholding. It explicitly details a 'flagging' (flaggning) event, which is the standard term for a major shareholding notification when a shareholder crosses a specific threshold (in this case, 10%). The document provides the identity of the holder, the number of shares, and the reason for the notification, which aligns perfectly with the definition of a Major Shareholding Notification (MRQ).
2025-05-12 Swedish
Interim / Quarterly Report 2025
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Delårsrapport Q1 2025' (Interim Report Q1 2025) for Apotea AB. It contains comprehensive financial statements, including income statements, balance sheets, cash flow analysis, and management commentary on business performance for the first quarter of 2025. It is a substantive financial report rather than a mere announcement or certification, fitting the definition of an Interim/Quarterly Report. Q1 2025
2025-05-08 Swedish
Interim / Quarterly Report 2025
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim report Q1 2025' and contains comprehensive financial statements, including net revenue, EBIT, cash flow, and balance sheet data for the period ending March 31, 2025. It provides a detailed analysis of financial performance, CEO commentary, and operational updates. It meets the criteria for an Interim/Quarterly Report (IR) as it contains substantive financial data and analysis for a period shorter than a full fiscal year. Q1 2025
2025-05-08 English
Annual Report (ESEF) 2024
Annual Report (ESEF) Classification · 1% confidence FY 2024
2025-04-29 Swedish
Kallelse till årsstämma i Apotea AB (publ)
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal 'Kallelse till årsstämma' (Notice of Annual General Meeting) for Apotea AB. It contains the agenda, proposals from the nomination committee, board proposals, and instructions for shareholders to participate, vote, and access documents. This is a standard proxy solicitation and meeting notice document, which falls under the Proxy Solicitation & Information Statement category.
2025-04-23 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.